Authors:
Isla, D
Rosell, R
Sanchez, JJ
Carrato, A
Felip, E
Camps, C
Artal, A
Gonzalez-Larriba, JL
Azagra, P
Alberola, J
Martin, C
Massuti, B
Citation: D. Isla et al., Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer, J CL ONCOL, 19(4), 2001, pp. 1071-1077
Authors:
Gonzalez-Larriba, JL
Serrano, S
Alvarez-Mon, M
Camacho, F
Casado, MA
Diaz-Perez, JL
Diaz-Rubio, E
Fosbrook, L
Guillem, V
Lopez-Lopez, JJ
Moreno-Nogueira, JA
Toribio, J
Citation: Jl. Gonzalez-larriba et al., Cost-effectiveness analysis of interferon as adjuvant therapy in high-riskmelanoma patients in Spain, EUR J CANC, 36(18), 2000, pp. 2344-2352
Authors:
Bellmunt, J
Guillem, V
Paz-Ares, L
Gonzalez-Larriba, JL
Carles, J
Batiste-Alentorn, E
Saenz, A
Lopez-Brea, M
Font, A
Nogue, M
Bastus, R
Climent, MA
de la Cruz, JJ
Albanell, J
Banus, JM
Gallardo, E
Diaz-Rubio, E
Cortes-Funes, H
Baselga, J
Citation: J. Bellmunt et al., Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium, J CL ONCOL, 18(18), 2000, pp. 3247-3255
Authors:
Monzo, M
Rosell, R
Sanchez, JJ
Lee, JS
O'Brate, A
Gonzalez-Larriba, JL
Alberola, V
Lorenzo, JC
Nunez, L
Ro, JY
Martin, C
Citation: M. Monzo et al., Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations, J CL ONCOL, 17(6), 1999, pp. 1786-1793
Authors:
Cardenal, F
Lopez-Cabrerizo, MP
Anton, A
Alberola, V
Massuti, B
Carrato, A
Barneto, I
Lomas, M
Garcia, M
Lianes, P
Montalar, J
Vadell, C
Gonzalez-Larriba, JL
Nguyen, B
Artal, A
Rosell, R
Citation: F. Cardenal et al., Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lungcancer, J CL ONCOL, 17(1), 1999, pp. 12-18